| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −13.7× | −1.8× | |
| Price / Book | 6.3× | 2.1× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −15.3× | −1.6× | |
| EV / EBITDA | −13.0× | −1.1× | |
| Earnings yield | −7.3% | −14.1% | |
| Free cash flow yield | −6.5% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,283.13 | −1.80% | $1.21T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.45 | −1.55% | $634.21B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $282.84 | −0.82% | $499.81B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $421.12 | −0.91% | $377.99B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.10 | −2.13% | $355.52B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $155.54 | −0.47% | $280.28B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.73 | −1.07% | $264.79B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $673.13 | −0.50% | $248.89B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.89 | −1.43% | $238.36B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.90 | −0.18% | $194.55B | 22.9× | 37.5% | +26.7% |
